Global Obsessive-Compulsive Disorder (OCD) Drugs Market is expected to grow with a CAGR of 9.7% in the forecast period of 2021 to 2028. The years considered for the study areas mentioned below.
Global Obsessive-Compulsive Disorder (OCD) drugs market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenarios.
The major players dealing in the global obsessive-compulsive disorder (OCD) drugs market are introducing a strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award, and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.
Sun Pharmaceutical Industries Ltd. is the dominating player in global obsessive-compulsive disorder (OCD) drugs market. The other key players existing in the market are H. LUNDBECK A/S, Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), Abbott, Eli Lilly and Company, Viatria Inc., , GlaxoSmithKline plc., Pfizer Inc., Mallinckrodt, Sebela Pharmaceuticals, Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila), Lupin Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC., Dr. Reddy’s Laboratories Ltd., , Wockhardt, Alvogen, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma), Par Pharmaceutical, Apotex Inc., Lannett, among others.
Sun Pharmaceutical Industries Ltd. headquarter is in Maharashtra, India, founded in 1983. The company mainly works in the area of pharmaceutical products. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients. The company operates its business through several business segments that are US Business, Indian Branded Generics Business, Emerging Markets, API Business, Global Consumer Healthcare Business, and Rest of the World, in which Indian Branded Generics Business is market focused product. The company has wide product categories such as Specialty Medications, Generic Medications, Over-the-Counter Medications, Active Pharmaceutical Ingredients, and Anti Retro Viral Medications, in which Generic Medications is the market focused category. The company is attaining lucrative growth through several strategic initiatives.
The company has wide presence across North America, South America, Europe, Asia-Pacific, Oceania, and CIS. The company also has various subsidiary companies such as Sun Pharmaceutical (Bangladesh) Limited, Sun Pharma Laboratories Limited (India), Sun Pharma Holdings (Mauritius), Sun Pharmaceutical Industries Inc. (United States of America), Sun Pharmaceutical Industries (Australia) Pty Limited (Australia) among others. as Thermo Trace Limited (Australia), Thermo Electron A/S (France), Jouan Limited (England), Jouan Nordic AS (Denmark), JSC Thermo Electron (Russia), among others.
H. LUNDBECK A/S
H. LUNDBECK A/S founded in 1915. The company’s headquarter is in Copenhagen, Denmark. The company is focused on treating millions of people suffering from brain disease with the specialized products. The company has wide product categories such as Neurological Disorders, Psychiatric Disorders, and Other Disease, in which Psychiatric Disorders is the market focused product. The company is attaining lucrative growth through several strategic initiatives.
The company has wide presence across Africa, Americas, Asia-Pacific, and Europe. The company also has various subsidiary companies such as Lundbeck S.A. (Belgium), CNS Pharma Pty Ltd (Australia), Lundbeck Austria GmbH (Austria), Lundbeck Export A/S (Denmark), Prexton Therapeutics S.A. (Switzerland) among others.
Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
Teva Pharmaceuticals USA, Inc., headquartered in New Jersey, U.S., founded in 1985. The company assist patients to live longer and healthier life with increasing access to quality health to millions of people around the world. The company has various product categories that are Generic Medicines, Specialty Medicines, and Biopharmaceuticals, in which Generic Medicines is the market focused product. The company is attaining lucrative growth through several strategic initiatives.
The company has presence across North America, Europe, Asia-Pacific, Middle East, Africa, and Latin America. The company also has various subsidiary companies such as Teva Canada (Canada), Ratiopharm (Germany), Mepha Schweiz AG (Switzerland), Merckle GmbH (Germany), PLIVA HRVATSKA d.o.o (Croatia), among others.